Page results
-
Information about our UCLH Charity, charity funds and associated charities.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
This information will give you an overview of BCG immunotherapy, how it is given and side effects it may cause.
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
UCLH will play a vital role in a new respiratory virus study.
-
While you're pregnant you will have a nominated professional lead which will be a midwife or an obstetrician.
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
UCLH has declared a climate and health emergency and has published an action plan to reach net zero carbon dioxide emissions.
File results
-
FOI/2024/0425 - Freedom of Information (FOI) structure, banding and job titles
-
FOI/2024/0423 - Giant cell arteritis (GCA) patient treatment
-
FOI/2024/0421 - Capital staffing nurses/ approved framework agencies/ escalated rates
-
FOI/2024/0420 - Commercialisation of NHS patient data
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0416 - Home dialysis treatment
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0412 - Healthcare travel costs scheme for patients
-
FOI2017125 Restraint of patients
-
FOI/2024/0385 - Immunoglobulin vials (by brands) distributed to patients